CA
NZ
UK
AU
IND
US
…
United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 2.64M | 4.11M | 3.25M | 3.23M | 5.88M |
| Net income | 2.11M | 3.25M | 2.58M | 2.57M | 4.66M |
| Gross profit | 5.03M | 6.46M | 5.41M | 6.70M | 8.18M |
| Reconciled depreciation | 0.11M | 0.10M | 0.11M | 0.14M | 0.15M |
| Ebit | 2.64M | 4.11M | 3.25M | 4.04M | 5.67M |
| Ebitda | 2.75M | 4.20M | 3.36M | 4.85M | 5.46M |
| Depreciation and amortization | 0.11M | 0.10M | 0.11M | 0.81M | -0.21M |
| Operating income | 2.24M | 3.65M | 2.86M | 4.04M | 5.67M |
| Other operating expenses | 8.30M | 8.54M | 8.02M | 8.66M | 8.26M |
| Interest expense | - | - | - | 1.62M | 0.57M |
| Tax provision | 0.54M | 0.86M | 0.64M | 0.66M | 1.22M |
| Income tax expense | 0.54M | 0.86M | 0.67M | 0.66M | 1.22M |
| Total revenue | 10.55M | 12.18M | 10.89M | 12.70M | 13.93M |
| Total operating expenses | 2.79M | 2.81M | 2.54M | 2.66M | 2.51M |
| Cost of revenue | 5.51M | 5.72M | 5.48M | 6.00M | 5.75M |
| Total other income expense net | 0.40M | 0.46M | 0.39M | -0.81M | 0.21M |
| Net income from continuing ops | 2.11M | 3.25M | 2.52M | 2.57M | 4.66M |
| Net income applicable to common shares | - | - | - | 2.57M | 4.66M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 13.11M | 13.80M | 13.36M | 10.64M | 12.24M |
| Other current assets | 0.53M | 0.39M | 0.37M | 0.20M | 0.19M |
| Total liab | 1.88M | 1.91M | 1.97M | 1.37M | 2.42M |
| Total stockholder equity | 11.23M | 11.88M | 11.39M | 9.27M | 9.82M |
| Other current liab | 1.18M | 1.49M | 1.36M | 1.34M | 1.74M |
| Common stock | 0.46M | 0.46M | 0.46M | 0.46M | 0.46M |
| Capital stock | 0.46M | 0.46M | 0.46M | 0.46M | 0.46M |
| Retained earnings | 10.77M | 11.42M | 10.93M | 8.81M | 9.36M |
| Other liab | - | - | - | - | 0.08M |
| Other assets | - | - | 0.00M | 0.11M | - |
| Cash | 1.25M | 1.88M | 8.24M | 0.83M | 0.53M |
| Total current liabilities | 1.67M | 1.91M | 1.53M | 1.37M | 2.34M |
| Current deferred revenue | 0.01M | - | 0.02M | - | 0.19M |
| Net debt | -1.25M | -1.88M | -8.24M | -0.83M | -0.53M |
| Short term debt | - | - | 0.02M | - | - |
| Other stockholder equity | - | - | - | - | 9.82M |
| Property plant equipment | - | - | - | 0.56M | 0.66M |
| Total current assets | 12.20M | 12.67M | 12.25M | 9.97M | 11.58M |
| Net tangible assets | - | - | - | 9.27M | 9.82M |
| Short term investments | 7.32M | 7.52M | 0.85M | 5.65M | 7.64M |
| Net receivables | 1.59M | 1.43M | 1.57M | 1.43M | 1.81M |
| Inventory | 1.51M | 1.45M | 1.22M | 1.67M | 1.41M |
| Accounts payable | 0.48M | 0.43M | 0.13M | 0.03M | 0.41M |
| Non currrent assets other | - | -7.19M | -0.00M | - | -0.08M |
| Non current assets total | 0.91M | 1.13M | 1.11M | 0.67M | 0.66M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 0.23M | -7.08M | 5.86M | 0.90M | -0.07M |
| Change to liabilities | - | - | - | -0.57M | 0.57M |
| Total cashflows from investing activities | 0.18M | -7.08M | 4.73M | 0.90M | -0.18M |
| Total cash from financing activities | -2.77M | -2.76M | -0.46M | -3.12M | -5.19M |
| Change to operating activities | - | - | - | -0.31M | 0.23M |
| Net income | 2.11M | 3.25M | 2.58M | 2.57M | 4.66M |
| Change in cash | -0.62M | -6.37M | 7.41M | 0.30M | -0.06M |
| Begin period cash flow | 1.88M | 8.24M | 0.83M | 0.53M | 0.59M |
| End period cash flow | 1.25M | 1.88M | 8.24M | 0.83M | 0.53M |
| Total cash from operating activities | 1.97M | 3.47M | 3.14M | 2.53M | 5.31M |
| Depreciation | 0.11M | 0.10M | 0.11M | 0.14M | 0.15M |
| Other cashflows from investing activities | -0.06M | -0.43M | 0.01M | - | - |
| Dividends paid | 2.77M | 2.76M | 0.46M | -3.12M | -5.19M |
| Change to inventory | -0.05M | -0.21M | 0.47M | -0.29M | 0.00M |
| Change to account receivables | -0.16M | 0.14M | -0.14M | 0.39M | -0.43M |
| Other cashflows from financing activities | - | - | 4.73M | 0.90M | -0.18M |
| Change to netincome | - | - | - | 0.88M | -0.05M |
| Capital expenditures | 0.06M | 0.43M | 0.17M | 0.08M | 0.12M |
| Change in working capital | -0.60M | 0.29M | 0.51M | -1.06M | 0.56M |
| Stock based compensation | - | - | 0.05M | - | - |
| Other non cash items | -0.03M | -0.04M | -0.11M | 1.08M | 0.01M |
| Free cash flow | 1.91M | 3.03M | 2.98M | 2.45M | 5.20M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| UG United-Guardian Inc |
-0.46 4.97% |
8.71 | 13.47 | 26.53 | 2.93 | 2.83 | 2.08 | 9.51 |
| PG Procter & Gamble Company |
-0.99 0.59% |
167.67 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
| LRLCF L'Oréal S.A |
- -% |
497.60 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
| LRLCY L’Oreal Co ADR |
-0.27 0.27% |
99.39 | 32.44 | 25.64 | 5.16 | 6.03 | 4.79 | 19.51 |
| UL Unilever PLC ADR |
-0.69 1.04% |
65.78 | 21.53 | 16.39 | 2.66 | 7.29 | 2.77 | 12.45 |
United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
| Name | Title | Year Born |
|---|---|---|
| Ms. Donna Vigilante | VP, R&D Mang. and Director of Technical Services | 1980 |
| Mr. Peter A. Hiltunen | Sr. VP & Production Mang. | 1959 |
| Ms. Beatriz Blanco | CEO, Pres & Director | NA |
| Ms. Andrea J. Young | CFO, Treasurer, Controller, Sec. & HR Mang. | 1969 |
| Ms. Donna Vigilante | President | 1981 |
| Ms. Andrea J. Young | CFO, Treasurer, Controller, Secretary & Human Resources Manager | 1969 |
| Mr. Peter A. Hiltunen | Senior VP of Production & Procurement and Production Manager | 1959 |
| Ms. Donna Vigilante | President & Director | 1981 |
| Ms. Denise Costrini | Marketing Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.29%
Communication Services
+0.51%
Consumer Cyclical
-0.08%
Consumer Defensive
-0.14%
Energy
+1.08%
Financial Services
+0.14%
Financials
-0.06%
Healthcare
+0.51%
Industrials
+0.47%
Real Estate
-0.23%
Technology
+2.03%
Utilities
-0.13%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...